The JSE was firmer on Wednesday, with its global peers mixed as investors digest unclear important details around the Covid-19 vaccine.

The enthusiasm that followed Pfizer’s vaccine breakthrough has faded as details about its production, distribution, performance and capabilities still need to be clarified. With this in mind, investors are aware that it may take months for the vaccine to be available...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now